Unibest

管线数据库

UB842

Omeprazole and Sodium Bicarbonate Capsules

UB842

ProductOmeprazole and Sodium Bicarbonate Capsules
StrengthEach capsule contains omeprazole 20mg and sodium bicarbonate 1100mg
IndicationsGastric ulcer; Duodenal ulcer; Gastrooesophageal reflux disease; Zollinger-Ellison syndrome
TherapeuticsGastroenterology & Hepatology
GMPCN - NMPA
RegistrationChina
ModalitiesSmall Molecule

Exclusive Summary

  • Differentiated Immediate-Release Profile: The addition of sodium bicarbonate enables rapid omeprazole absorption, providing significantly faster relief than traditional delayed-release capsules and controlling nocturnal acid breakthrough.
  • Favorable Competitive Landscape: Unlike the heavily saturated plain omeprazole market, this combination has higher formulation barriers and fewer generic competitors, protecting distributors from severe price wars.
  • Massive Market Demand: Driven by a global GERD prevalence of 13-19% and hundreds of millions of patients reliably continuously demanding highly effective PPI therapies.
  • Overwhelming Cost Advantage: Leveraging China's vertically integrated API-formulation supply chain ensures highly competitive pricing, guaranteeing lucrative profit margins for overseas distributors.

我们能如何帮助您?

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →